YD Bio YDES
NASDAQ YDES
$6.19 -0.99 (-13.79%)
At close: Nov 6, 2026 · 4:00 PM EST

YD Bio (YDES) Receivables - Net (2024 - 2026)

Updated

YD Bio's Receivables - Net was $223,067 in the quarter ended Jun 30, 2026, up 119.9% from $101,430 a year earlier.

Analysis

YD Bio (YDES) Receivables - Net (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Receivables - Net at YD Bio came in at $167,477, up 93.4% from the prior year.

  • In earlier years, Receivables - Net was $86,582 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 YD Bio 397.65 Mn 385.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 223,067.00
Dec 31, 2025 167,477.00
Jun 30, 2025 101,430.00
Dec 31, 2024 86,582.00
API Access

YD Bio Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=YDES&period=max&api_key=YOUR_API_KEY